Status: Recruiting
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
Researchers are evaluating the safety of allogeneic Adipose Derived Mesenchymal Stem Cells (AMSC) use during hemodialysis arteriovenous fistula and arterial bypass creation and its efficacy on improving access maturation and primary anastomotic patency.
Participants needed: 15
Trial details
Phase: Phase 1Age: 18-85Biological sex: AllType: InterventionalSponsor: Houssam Farres, M.D.Updated: Jul 10, 2026Locations: 1
Eligibility criteria
Patient between 18 and 85 years old [+4]
Malignancy or treatment for malignancy within the previous 6 months [+5]